Skip to main content
Improve Medical Instruments CO., Ltd. logo

Improve Medical Instruments CO., Ltd. — Investor Relations & Filings

Ticker · 300030 ISIN · CNE100000JL3 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,954 across all filing types
Latest filing 2021-04-20 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 300030

About Improve Medical Instruments CO., Ltd.

https://www.improve-medical.com

Improve Medical Instruments CO., Ltd. focuses on the development, production, and distribution of clinical laboratory and nursing solutions. The core product range includes evacuated blood collection systems, specimen collection and transport media, and laboratory automation equipment. The company also provides medical imaging components and point-of-care testing (POCT) systems. By integrating research and development with advanced manufacturing, the organization supports clinical diagnostics and patient care through high-precision tools designed for healthcare facilities and research laboratories. Its offerings are characterized by a commitment to diagnostic safety and efficiency across global markets.

Recent filings

Filing Released Lang Actions
2020年年度审计报告
Audit Report / Information Classification · 95% confidence The document is titled as an "审计报告及财务报表" which translates to "Audit Report and Financial Statements" for the fiscal year 2020. It includes detailed audit opinions, key audit matters, and comprehensive financial statements such as consolidated and parent company balance sheets, profit and loss statements, and cash flow statements. The presence of an auditor's opinion, audit basis, and detailed financial data confirms this is a full audit report with financial statements. The document length is substantial (15,000 characters), indicating it is the full report, not just an announcement or certification. Therefore, the document fits the category of an Audit Report / Information (AR). FY 2020
2021-04-20 Chinese
监事会决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of Guangzhou Yangpu Medical Technology Co., Ltd. It details the approval of various reports and proposals including the 2020 Annual Report, 2020 Annual Financial Statements, 2021 Q1 Report, profit distribution plan, internal control report, and other governance matters. The document repeatedly states that the full reports are available on the designated disclosure website and that these resolutions will be submitted to the shareholders' meeting for approval. The document itself does not contain the full annual report or financial statements but is a formal announcement of the Supervisory Board's meeting resolutions regarding these reports and proposals. The document length is 4166 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, according to the "Menu vs Meal" rule, this document is best classified as a Regulatory Filing (RNS) because it is an official announcement of meeting resolutions and references to reports rather than the reports themselves.
2021-04-20 Chinese
独立董事关于第五届董事会第八次会议相关事项的事前认可意见
Board/Management Information Classification · 95% confidence The document is a statement from independent directors of Guangzhou Yangpu Medical Technology Co., Ltd. providing prior approval opinions on matters to be discussed at the company's fifth board of directors' eighth meeting. It includes opinions on subsidiary restructuring and related party transactions, reappointment of the audit firm for 2021, and anticipated related party transactions for 2021. The document is focused on board-level approvals and opinions rather than financial results, audit reports, or regulatory filings. It does not contain financial statements or detailed financial data. The content aligns with announcements related to board or management information, specifically about board meeting matters and approvals. Therefore, the document fits best under Board/Management Information (MANG). The document length is short and it is not a report publication announcement or certification letter, so it is not RPA or RNS.
2021-04-20 Chinese
关于续聘会计师事务所的公告
Audit Report / Information Classification · 95% confidence The document is an announcement regarding the reappointment of an audit firm (立信会计师事务所) for the 2021 fiscal year. It details the audit firm's background, independence, audit fees, and the board's approval process. It does not contain actual audited financial statements or detailed audit results, but rather the company's decision and procedural information about continuing the audit engagement. The document length is 2844 characters, which is relatively short and consistent with an announcement rather than a full audit report. Therefore, this is not the audit report itself but an announcement about the audit firm reappointment, which fits best under Audit Report / Information (AR) as it relates to audit matters but is not a full annual report or financial statement filing. FY 2020
2021-04-20 Chinese
关于公司2020年度利润分配预案的公告
Notice of Dividend Amount Classification · 95% confidence The document is an announcement regarding the 2020 annual profit distribution plan of Guangzhou Yangpu Medical Technology Co., Ltd. It includes details about the proposed cash dividend per share, the legal and regulatory compliance of the plan, and opinions from independent directors and the supervisory board. The document states that the profit distribution plan will be submitted to the 2020 annual shareholders' meeting for approval. The document is relatively short (1370 characters) and serves as a formal announcement of a dividend proposal rather than the dividend payment notice itself. It does not contain actual financial statements or comprehensive financial data but focuses on the dividend distribution plan and related approvals. Therefore, it fits best under the category of Notice of Dividend Amount (DIV), as it announces the dividend amount and related details for shareholders.
2021-04-20 Chinese
年报披露提示性公告
Report Publication Announcement Classification · 95% confidence The document is a short announcement (430 characters) regarding the disclosure of the company's 2020 Annual Report. It states that the 2020 Annual Report and its summary were approved and published on April 21, 2021, and provides a link to the official disclosure website. The document does not contain the actual annual report or financial data but serves as a notification to investors to review the report elsewhere. According to the 'MENU VS MEAL' rule, this is a report publication announcement, not the report itself.
2021-04-20 Chinese

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.